ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Functional Characterization of RELA Fusion Ependymoma as a Basis for Therapeutic Targeting | St. Jude Children’s Research Hospital / Stephen Mack, PhD | 'A' Award Grants | 2018 | Tennessee |
Genetic Susceptibility to Pediatric Osteosarcoma and Interaction with Measures of Childhood Growth | Duke University / Kyle Walsh, Ph.D. | 'A' Award Grants | 2014 | North Carolina |
Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL | Temple University / Christian Hurtz, PhD | 'A' Award Grants | 2022 | Pennsylvania |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma | The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD | 'A' Award Grants | 2019 | California |
The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes | Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD | 'A' Award Grants | 2021 | Massachusetts |
Novel Approaches to AML Differentiation Therapy | Dana-Farber Cancer Institute / Andrew Lane, MD/PhD | 'A' Award Grants | 2017 | Massachusetts |
Targeting the LIN28 Pathway in ATRT | The Johns Hopkins University School of Medicine / Eric Raabe, MD, PhD | 'A' Award Grants | 2015 | Maryland |
Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML | Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD | 'A' Award Grants | 2012 | Washington |
Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia | Washington University / Grant Challen, PhD | 'A' Award Grants | 2012 | Missouri |
The Role of Inherited MLL3 Single Nucleotide Variants and Fetal Epigenetic Programming in Infant Leukemogenesis | Washington University / Jeffrey Magee, MD/PhD | 'A' Award Grants | 2016 | Missouri |